Breaking News

ABL Supports Fill/Finish of COVID-19 Vaccine Candidate

Utilizes its aseptic fill/finish facility to support clients' COVID-19 vaccine development

By: Contract Pharma

Contract Pharma Staff

Advanced BioScience Laboratories, Inc. (ABL), a global contract development and manufacturing organization (CDMO) and contract research organization (CRO) for biotherapeutics, oncolytics and vaccines has completed the aseptic fill/finish of a novel COVID-19 vaccine candidate for a confidential customer.   ABL said it readied the fill/finish line within a week to vial the vaccine for upcoming clinical trials.   In addition to this completed effort, ABL said it is in negotiations with multiple...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters